ID: ALA5201369

Max Phase: Preclinical

Molecular Formula: C32H37F2N3O4S

Molecular Weight: 597.73

Associated Items:

Representations

Canonical SMILES:  CCCCOC(=O)NS(=O)(=O)c1ccc(CCC)cc1-c1cc(F)c(Cn2c(C(C)(C)C)nc3ccccc32)c(F)c1

Standard InChI:  InChI=1S/C32H37F2N3O4S/c1-6-8-16-41-31(38)36-42(39,40)29-15-14-21(11-7-2)17-23(29)22-18-25(33)24(26(34)19-22)20-37-28-13-10-9-12-27(28)35-30(37)32(3,4)5/h9-10,12-15,17-19H,6-8,11,16,20H2,1-5H3,(H,36,38)

Standard InChI Key:  LQKIBYRAMKDYMO-UHFFFAOYSA-N

Associated Targets(Human)

Type-1 angiotensin II receptor 5176 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Angiotensin II type 2 (AT-2) receptor 2549 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 597.73Molecular Weight (Monoisotopic): 597.2473AlogP: 7.49#Rotatable Bonds: 10
Polar Surface Area: 90.29Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.93CX Basic pKa: 5.49CX LogP: 7.10CX LogD: 8.06
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.19Np Likeness Score: -0.98

References

1. Roy T, Petersen NN, Gopalan G, Gising J, Hallberg M, Larhed M..  (2022)  2-Alkyl substituted benzimidazoles as a new class of selective AT2 receptor ligands.,  66  [PMID:35576659] [10.1016/j.bmc.2022.116804]

Source